Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 1984;64:417-420
© 1984 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by GALLUP, D. G.
Right arrow Articles by STOCK, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GALLUP, D. G.
Right arrow Articles by STOCK, R. J.

Adenocarcinoma of the Endometrium in Women 40 Years of Age or Younger

DONALD G. GALLUP, MD and RICHARD J. STOCK, MD

From the Department of Obstetrics and Gynecology and Pathology, Naval Hospital, Portsmouth, Virginia.

Abstract

Excluding cases associated with oral sequential contraceptives, adenocarcinoma of the endometrium in young women is rare, constituting about 3% of endometrial carcinomas. The present report, based on findings from one institution, notes that women 40 years of age or younger comprised 14.4% of the 111 patients with adenocarcinoma of the endometrium. Factors analyzed in patients 40 years of age or younger (group A) as compared with those 41 years of age or older (group B) include the following: obesity 43.8% (A) versus 17.9% (B), nulliparity 44% (A) versus 10.5% (B), hypertension 31.2% (A) versus 42.1% (B), and diabetes 6.2% (A) versus 21.1% (B). Patients in group A tended to have a well-differentiated tumor, and 31.2% had polycystic ovaries. Awareness of risk factors in young women who develop endometrial adenocarcinoma leads to earlier diagnosis and will preserve the historically excellent survival rate of young women.




This article has been cited by other articles:


Home page
 Hum Reprod UpdateHome page
F. M. Horne and D. L. Blithe
Progesterone receptor modulators and the endometrium: changes and consequences
Hum. Reprod. Update, November 1, 2007; 13(6): 567 - 580.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
N. K. Lee, M. K. Cheung, J. Y. Shin, A. Husain, N. N. Teng, J. S. Berek, D. S. Kapp, K. Osann, and J. K. Chan
Prognostic Factors for Uterine Cancer in Reproductive-Aged Women
Obstet. Gynecol., March 1, 2007; 109(3): 655 - 662.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
T. Yahata, K. Fujita, Y. Aoki, and K. Tanaka
Long-term conservative therapy for endometrial adenocarcinoma in young women
Hum. Reprod., April 1, 2006; 21(4): 1070 - 1075.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R. R. Barakat, B. N. Bundy, N. M. Spirtos, J. Bell, and R. S. Mannel
Randomized Double-Blind Trial of Estrogen Replacement Therapy Versus Placebo in Stage I or II Endometrial Cancer: A Gynecologic Oncology Group Study
J. Clin. Oncol., February 1, 2006; 24(4): 587 - 592.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
C. Walsh, C. Holschneider, Y. Hoang, K. Tieu, B. Karlan, and I. Cass
Coexisting Ovarian Malignancy in Young Women With Endometrial Cancer
Obstet. Gynecol., October 1, 2005; 106(4): 693 - 699.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
M. M. Leitao Jr and D. S. Chi
Fertility-Sparing Options for Patients with Gynecologic Malignancies
Oncologist, September 1, 2005; 10(8): 613 - 622.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
W. H. Xu, C. E. Matthews, Y. B. Xiang, W. Zheng, Z. X. Ruan, J. R. Cheng, Y. T. Gao, and X. O. Shu
Effect of Adiposity and Fat Distribution on Endometrial Cancer Risk in Shanghai Women
Am. J. Epidemiol., May 15, 2005; 161(10): 939 - 947.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
P. T. Soliman, J. C. Oh, K. M. Schmeler, C. C. Sun, B. M. Slomovitz, D. M. Gershenson, T. W. Burke, and K. H. Lu
Risk Factors for Young Premenopausal Women With Endometrial Cancer
Obstet. Gynecol., March 1, 2005; 105(3): 575 - 580.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Petridou, C. Mantzoros, N. Dessypris, P. Koukoulomatis, C. Addy, Z. Voulgaris, G. Chrousos, and D. Trichopoulos
Plasma Adiponectin Concentrations in Relation to Endometrial Cancer: A Case-Control Study in Greece
J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 993 - 997.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. E. Hale, C. L. Hughes, and J. M. Cline
Endometrial Cancer: Hormonal Factors, the Perimenopausal ""Window of Risk,"" and Isoflavones
J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 3 - 15.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. L. Arnett-Mansfield, A. deFazio, G. V. Wain, R. C. Jaworski, K. Byth, P. A. Mote, and C. L. Clarke
Relative Expression of Progesterone Receptors A and B in Endometrioid Cancers of the Endometrium
Cancer Res., June 1, 2001; 61(11): 4576 - 4582.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
H. Shibahara, M. Shigeta, H. Toji, E. Wakimoto, S. Adachi, T. Ogasawara, T. Takemura, and K. Koyama
Successful pregnancy in an infertile patient with conservatively treated endometrial adenocarcinoma after transfer of embryos obtained by intracytoplasmic sperm injection: Case report
Hum. Reprod., July 1, 1999; 14(7): 1908 - 1911.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
P. G. Rose
Endometrial Carcinoma
N. Engl. J. Med., August 29, 1996; 335(9): 640 - 649.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the American College of Obstetricians and Gynecologists.